Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The FDA approved a new Pfizer drug for hair loss in teens.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The commentary explains that a balance of HR protein and putrescine is important for normal hair growth.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

PADI4 enzyme slows down cell growth in developing hair follicles.

Apremilast showed mixed results for treating severe alopecia areata.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

TMPRSS6 is crucial for controlling hepcidin and normal iron absorption.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

AVT is highly conserved and may have antimicrobial properties.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Adenosine treatment thickens hair in Caucasian men with hair loss.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

ALDOA levels drop in hair cells during hair loss.

Iron supplements may reverse premature graying in iron-deficient individuals; ingrown nails are common in diabetics with certain risk factors; topical finasteride may reduce scalp DHT as effectively as oral finasteride; monilethrix treatment is challenging but some medications can help.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.